Pre-order Enquiry
Request Free Sample
Global and United States Transdermal Therapeutic Systems (TTS) Market Insights, Forecast to 2027
SKU ID : QYR-19241866 | Publishing Date : 28-Sep-2021 | No. of pages : 161
Detailed TOC of Global and United States Transdermal Therapeutic Systems (TTS) Market Insights, Forecast to 2027
1 Study Coverage1.1 Transdermal Therapeutic Systems (TTS) Product Introduction
1.2 Market by Type
1.2.1 Global Transdermal Therapeutic Systems (TTS) Market Size Growth Rate by Type
1.2.2 Methyl Salicylate
1.2.3 Nitroglycerin
1.2.4 Fentanyl
1.2.5 Nicotine
1.2.6 Rivastigmine
1.2.7 Estradiol
1.2.8 Others
1.3 Market by Application
1.3.1 Global Transdermal Therapeutic Systems (TTS) Market Size Growth Rate by Application
1.3.2 OTC Channel
1.3.3 Retail Channel
1.3.4 E-Commerce Channel
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Transdermal Therapeutic Systems (TTS) Market Size, Estimates and Forecasts
2.1.1 Global Transdermal Therapeutic Systems (TTS) Revenue 2016-2027
2.1.2 Global Transdermal Therapeutic Systems (TTS) Sales 2016-2027
2.2 Global Transdermal Therapeutic Systems (TTS), Market Size by Region: 2016 VS 2021 VS 2027
2.3 Transdermal Therapeutic Systems (TTS) Historical Market Size by Region (2016-2021)
2.3.1 Global Transdermal Therapeutic Systems (TTS) Retrospective Market Scenario in Sales by Region: 2016-2021
2.3.2 Global Transdermal Therapeutic Systems (TTS) Retrospective Market Scenario in Revenue by Region: 2016-2021
2.4 Transdermal Therapeutic Systems (TTS) Market Estimates and Projections by Region (2022-2027)
2.4.1 Global Transdermal Therapeutic Systems (TTS) Sales Forecast by Region (2022-2027)
2.4.2 Global Transdermal Therapeutic Systems (TTS) Revenue Forecast by Region (2022-2027)
3 Global Transdermal Therapeutic Systems (TTS) Competitor Landscape by Players
3.1 Global Top Transdermal Therapeutic Systems (TTS) Manufacturers by Sales
3.1.1 Global Transdermal Therapeutic Systems (TTS) Sales by Manufacturer (2016-2021)
3.1.2 Global Transdermal Therapeutic Systems (TTS) Sales Market Share by Manufacturer (2016-2021)
3.2 Global Top Transdermal Therapeutic Systems (TTS) Manufacturers by Revenue
3.2.1 Key Transdermal Therapeutic Systems (TTS) Manufacturers Covered: Ranking by Revenue
3.2.2 Global Transdermal Therapeutic Systems (TTS) Revenue by Manufacturers (2016-2021)
3.2.3 Global Transdermal Therapeutic Systems (TTS) Revenue Share by Manufacturers (2016-2021)
3.2.4 Global Transdermal Therapeutic Systems (TTS) Market Concentration Ratio (CR5 and HHI) (2016-2021)
3.2.5 Global Top 10 and Top 5 Companies by Transdermal Therapeutic Systems (TTS) Revenue in 2020
3.2.6 Global Transdermal Therapeutic Systems (TTS) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Transdermal Therapeutic Systems (TTS) Price by Manufacturers
3.4 Global Transdermal Therapeutic Systems (TTS) Manufacturing Base Distribution, Product Types
3.4.1 Transdermal Therapeutic Systems (TTS) Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Transdermal Therapeutic Systems (TTS) Product Type
3.4.3 Date of International Manufacturers Enter into Transdermal Therapeutic Systems (TTS) Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2016-2027)
4.1 Global Transdermal Therapeutic Systems (TTS) Market Size by Type (2016-2021)
4.1.1 Global Transdermal Therapeutic Systems (TTS) Sales by Type (2016-2021)
4.1.2 Global Transdermal Therapeutic Systems (TTS) Revenue by Type (2016-2021)
4.1.3 Transdermal Therapeutic Systems (TTS) Average Selling Price (ASP) by Type (2016-2021)
4.2 Global Transdermal Therapeutic Systems (TTS) Market Size Forecast by Type (2022-2027)
4.2.1 Global Transdermal Therapeutic Systems (TTS) Sales Forecast by Type (2022-2027)
4.2.2 Global Transdermal Therapeutic Systems (TTS) Revenue Forecast by Type (2022-2027)
4.2.3 Transdermal Therapeutic Systems (TTS) Average Selling Price (ASP) Forecast by Type (2022-2027)
5 Breakdown Data by Application (2016-2027)
5.1 Global Transdermal Therapeutic Systems (TTS) Market Size by Application (2016-2021)
5.1.1 Global Transdermal Therapeutic Systems (TTS) Sales by Application (2016-2021)
5.1.2 Global Transdermal Therapeutic Systems (TTS) Revenue by Application (2016-2021)
5.1.3 Transdermal Therapeutic Systems (TTS) Price by Application (2016-2021)
5.2 Transdermal Therapeutic Systems (TTS) Market Size Forecast by Application (2022-2027)
5.2.1 Global Transdermal Therapeutic Systems (TTS) Sales Forecast by Application (2022-2027)
5.2.2 Global Transdermal Therapeutic Systems (TTS) Revenue Forecast by Application (2022-2027)
5.2.3 Global Transdermal Therapeutic Systems (TTS) Price Forecast by Application (2022-2027)
6 United States by Players, Type and Application
6.1 United States Transdermal Therapeutic Systems (TTS) Market Size YoY Growth 2016-2027
6.1.1 United States Transdermal Therapeutic Systems (TTS) Sales YoY Growth 2016-2027
6.1.2 United States Transdermal Therapeutic Systems (TTS) Revenue YoY Growth 2016-2027
6.1.3 United States Transdermal Therapeutic Systems (TTS) Market Share in Global Market 2016-2027
6.2 United States Transdermal Therapeutic Systems (TTS) Market Size by Players (International and Local Players)
6.2.1 United States Top Transdermal Therapeutic Systems (TTS) Players by Sales (2016-2021)
6.2.2 United States Top Transdermal Therapeutic Systems (TTS) Players by Revenue (2016-2021)
6.3 United States Transdermal Therapeutic Systems (TTS) Historic Market Review by Type (2016-2021)
6.3.1 United States Transdermal Therapeutic Systems (TTS) Sales Market Share by Type (2016-2021)
6.3.2 United States Transdermal Therapeutic Systems (TTS) Revenue Market Share by Type (2016-2021)
6.3.3 United States Transdermal Therapeutic Systems (TTS) Price by Type (2016-2021)
6.4 United States Transdermal Therapeutic Systems (TTS) Market Estimates and Forecasts by Type (2022-2027)
6.4.1 United States Transdermal Therapeutic Systems (TTS) Sales Forecast by Type (2022-2027)
6.4.2 United States Transdermal Therapeutic Systems (TTS) Revenue Forecast by Type (2022-2027)
6.4.3 United States Transdermal Therapeutic Systems (TTS) Price Forecast by Type (2022-2027)
6.5 United States Transdermal Therapeutic Systems (TTS) Historic Market Review by Application (2016-2021)
6.5.1 United States Transdermal Therapeutic Systems (TTS) Sales Market Share by Application (2016-2021)
6.5.2 United States Transdermal Therapeutic Systems (TTS) Revenue Market Share by Application (2016-2021)
6.5.3 United States Transdermal Therapeutic Systems (TTS) Price by Application (2016-2021)
6.6 United States Transdermal Therapeutic Systems (TTS) Market Estimates and Forecasts by Application (2022-2027)
6.6.1 United States Transdermal Therapeutic Systems (TTS) Sales Forecast by Application (2022-2027)
6.6.2 United States Transdermal Therapeutic Systems (TTS) Revenue Forecast by Application (2022-2027)
6.6.3 United States Transdermal Therapeutic Systems (TTS) Price Forecast by Application (2022-2027)
7 North America
7.1 North America Transdermal Therapeutic Systems (TTS) Market Size YoY Growth 2016-2027
7.2 North America Transdermal Therapeutic Systems (TTS) Market Facts & Figures by Country
7.2.1 North America Transdermal Therapeutic Systems (TTS) Sales by Country (2016-2021)
7.2.2 North America Transdermal Therapeutic Systems (TTS) Revenue by Country (2016-2021)
7.2.3 United States
7.2.4 Canada
8 Asia Pacific
8.1 Asia Pacific Transdermal Therapeutic Systems (TTS) Market Size YoY Growth 2016-2027
8.2 Asia Pacific Transdermal Therapeutic Systems (TTS) Market Facts & Figures by Region
8.2.1 Asia Pacific Transdermal Therapeutic Systems (TTS) Sales by Region (2016-2021)
8.2.2 Asia Pacific Transdermal Therapeutic Systems (TTS) Revenue by Region (2016-2021)
8.2.3 China
8.2.4 Japan
8.2.5 South Korea
8.2.6 India
8.2.7 Australia
8.2.8 Australia
8.2.9 Indonesia
8.2.10 Thailand
8.2.11 Malaysia
9 Europe
9.1 Europe Transdermal Therapeutic Systems (TTS) Market Size YoY Growth 2016-2027
9.2 Europe Transdermal Therapeutic Systems (TTS) Market Facts & Figures by Country
9.2.1 Europe Transdermal Therapeutic Systems (TTS) Sales by Country (2016-2021)
9.2.2 Europe Transdermal Therapeutic Systems (TTS) Revenue by Country (2016-2021)
9.2.3 Germany
9.2.4 France
9.2.5 U.K.
9.2.6 Italy
10 Latin America
10.1 Latin America Transdermal Therapeutic Systems (TTS) Market Size YoY Growth 2016-2027
10.2 Latin America Transdermal Therapeutic Systems (TTS) Market Facts & Figures by Country
10.2.1 Latin America Transdermal Therapeutic Systems (TTS) Sales by Country (2016-2021)
10.2.2 Latin America Transdermal Therapeutic Systems (TTS) Revenue by Country (2016-2021)
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Transdermal Therapeutic Systems (TTS) Market Size YoY Growth 2016-2027
11.2 Middle East and Africa Transdermal Therapeutic Systems (TTS) Market Facts & Figures by Country
11.2.1 Middle East and Africa Transdermal Therapeutic Systems (TTS) Sales by Country (2016-2021)
11.2.2 Middle East and Africa Transdermal Therapeutic Systems (TTS) Revenue by Country (2016-2021)
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 UAE
12 Company Profiles
12.1 Hisamitsu
12.1.1 Hisamitsu Corporation Information
12.1.2 Hisamitsu Description and Business Overview
12.1.3 Hisamitsu Transdermal Therapeutic Systems (TTS) Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Hisamitsu Transdermal Therapeutic Systems (TTS) Products Offered
12.1.5 Hisamitsu Recent Development
12.2 Mylan
12.2.1 Mylan Corporation Information
12.2.2 Mylan Description and Business Overview
12.2.3 Mylan Transdermal Therapeutic Systems (TTS) Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Mylan Transdermal Therapeutic Systems (TTS) Products Offered
12.2.5 Mylan Recent Development
12.3 GSK
12.3.1 GSK Corporation Information
12.3.2 GSK Description and Business Overview
12.3.3 GSK Transdermal Therapeutic Systems (TTS) Sales, Revenue and Gross Margin (2016-2021)
12.3.4 GSK Transdermal Therapeutic Systems (TTS) Products Offered
12.3.5 GSK Recent Development
12.4 Novartis
12.4.1 Novartis Corporation Information
12.4.2 Novartis Description and Business Overview
12.4.3 Novartis Transdermal Therapeutic Systems (TTS) Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Novartis Transdermal Therapeutic Systems (TTS) Products Offered
12.4.5 Novartis Recent Development
12.5 Teve (Actavis)
12.5.1 Teve (Actavis) Corporation Information
12.5.2 Teve (Actavis) Description and Business Overview
12.5.3 Teve (Actavis) Transdermal Therapeutic Systems (TTS) Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Teve (Actavis) Transdermal Therapeutic Systems (TTS) Products Offered
12.5.5 Teve (Actavis) Recent Development
12.6 Nitto Denko
12.6.1 Nitto Denko Corporation Information
12.6.2 Nitto Denko Description and Business Overview
12.6.3 Nitto Denko Transdermal Therapeutic Systems (TTS) Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Nitto Denko Transdermal Therapeutic Systems (TTS) Products Offered
12.6.5 Nitto Denko Recent Development
12.7 Johnson & Johnson
12.7.1 Johnson & Johnson Corporation Information
12.7.2 Johnson & Johnson Description and Business Overview
12.7.3 Johnson & Johnson Transdermal Therapeutic Systems (TTS) Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Johnson & Johnson Transdermal Therapeutic Systems (TTS) Products Offered
12.7.5 Johnson & Johnson Recent Development
12.8 Lohmann
12.8.1 Lohmann Corporation Information
12.8.2 Lohmann Description and Business Overview
12.8.3 Lohmann Transdermal Therapeutic Systems (TTS) Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Lohmann Transdermal Therapeutic Systems (TTS) Products Offered
12.8.5 Lohmann Recent Development
12.9 Teikoku Seiyaku
12.9.1 Teikoku Seiyaku Corporation Information
12.9.2 Teikoku Seiyaku Description and Business Overview
12.9.3 Teikoku Seiyaku Transdermal Therapeutic Systems (TTS) Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Teikoku Seiyaku Transdermal Therapeutic Systems (TTS) Products Offered
12.9.5 Teikoku Seiyaku Recent Development
12.10 Pfizer
12.10.1 Pfizer Corporation Information
12.10.2 Pfizer Description and Business Overview
12.10.3 Pfizer Transdermal Therapeutic Systems (TTS) Sales, Revenue and Gross Margin (2016-2021)
12.10.4 Pfizer Transdermal Therapeutic Systems (TTS) Products Offered
12.10.5 Pfizer Recent Development
12.11 Hisamitsu
12.11.1 Hisamitsu Corporation Information
12.11.2 Hisamitsu Description and Business Overview
12.11.3 Hisamitsu Transdermal Therapeutic Systems (TTS) Sales, Revenue and Gross Margin (2016-2021)
12.11.4 Hisamitsu Transdermal Therapeutic Systems (TTS) Products Offered
12.11.5 Hisamitsu Recent Development
12.12 Lingrui
12.12.1 Lingrui Corporation Information
12.12.2 Lingrui Description and Business Overview
12.12.3 Lingrui Transdermal Therapeutic Systems (TTS) Sales, Revenue and Gross Margin (2016-2021)
12.12.4 Lingrui Products Offered
12.12.5 Lingrui Recent Development
12.13 Sanofi
12.13.1 Sanofi Corporation Information
12.13.2 Sanofi Description and Business Overview
12.13.3 Sanofi Transdermal Therapeutic Systems (TTS) Sales, Revenue and Gross Margin (2016-2021)
12.13.4 Sanofi Products Offered
12.13.5 Sanofi Recent Development
12.14 UCB Pharma
12.14.1 UCB Pharma Corporation Information
12.14.2 UCB Pharma Description and Business Overview
12.14.3 UCB Pharma Transdermal Therapeutic Systems (TTS) Sales, Revenue and Gross Margin (2016-2021)
12.14.4 UCB Pharma Products Offered
12.14.5 UCB Pharma Recent Development
12.15 Dr. Reddy's Laboratories
12.15.1 Dr. Reddy's Laboratories Corporation Information
12.15.2 Dr. Reddy's Laboratories Description and Business Overview
12.15.3 Dr. Reddy's Laboratories Transdermal Therapeutic Systems (TTS) Sales, Revenue and Gross Margin (2016-2021)
12.15.4 Dr. Reddy's Laboratories Products Offered
12.15.5 Dr. Reddy's Laboratories Recent Development
12.16 Qizheng
12.16.1 Qizheng Corporation Information
12.16.2 Qizheng Description and Business Overview
12.16.3 Qizheng Transdermal Therapeutic Systems (TTS) Sales, Revenue and Gross Margin (2016-2021)
12.16.4 Qizheng Products Offered
12.16.5 Qizheng Recent Development
12.17 Endo
12.17.1 Endo Corporation Information
12.17.2 Endo Description and Business Overview
12.17.3 Endo Transdermal Therapeutic Systems (TTS) Sales, Revenue and Gross Margin (2016-2021)
12.17.4 Endo Products Offered
12.17.5 Endo Recent Development
12.18 Mundipharma
12.18.1 Mundipharma Corporation Information
12.18.2 Mundipharma Description and Business Overview
12.18.3 Mundipharma Transdermal Therapeutic Systems (TTS) Sales, Revenue and Gross Margin (2016-2021)
12.18.4 Mundipharma Products Offered
12.18.5 Mundipharma Recent Development
12.19 Huarun 999
12.19.1 Huarun 999 Corporation Information
12.19.2 Huarun 999 Description and Business Overview
12.19.3 Huarun 999 Transdermal Therapeutic Systems (TTS) Sales, Revenue and Gross Margin (2016-2021)
12.19.4 Huarun 999 Products Offered
12.19.5 Huarun 999 Recent Development
12.20 Haw Par
12.20.1 Haw Par Corporation Information
12.20.2 Haw Par Description and Business Overview
12.20.3 Haw Par Transdermal Therapeutic Systems (TTS) Sales, Revenue and Gross Margin (2016-2021)
12.20.4 Haw Par Products Offered
12.20.5 Haw Par Recent Development
12.21 Nichiban
12.21.1 Nichiban Corporation Information
12.21.2 Nichiban Description and Business Overview
12.21.3 Nichiban Transdermal Therapeutic Systems (TTS) Sales, Revenue and Gross Margin (2016-2021)
12.21.4 Nichiban Products Offered
12.21.5 Nichiban Recent Development
12.22 Mentholatum Company
12.22.1 Mentholatum Company Corporation Information
12.22.2 Mentholatum Company Description and Business Overview
12.22.3 Mentholatum Company Transdermal Therapeutic Systems (TTS) Sales, Revenue and Gross Margin (2016-2021)
12.22.4 Mentholatum Company Products Offered
12.22.5 Mentholatum Company Recent Development
12.23 Laboratoires Genevrier
12.23.1 Laboratoires Genevrier Corporation Information
12.23.2 Laboratoires Genevrier Description and Business Overview
12.23.3 Laboratoires Genevrier Transdermal Therapeutic Systems (TTS) Sales, Revenue and Gross Margin (2016-2021)
12.23.4 Laboratoires Genevrier Products Offered
12.23.5 Laboratoires Genevrier Recent Development
12.24 Beijing Tide Pharmaceutical
12.24.1 Beijing Tide Pharmaceutical Corporation Information
12.24.2 Beijing Tide Pharmaceutical Description and Business Overview
12.24.3 Beijing Tide Pharmaceutical Transdermal Therapeutic Systems (TTS) Sales, Revenue and Gross Margin (2016-2021)
12.24.4 Beijing Tide Pharmaceutical Products Offered
12.24.5 Beijing Tide Pharmaceutical Recent Development
12.25 Luye Pharma Group
12.25.1 Luye Pharma Group Corporation Information
12.25.2 Luye Pharma Group Description and Business Overview
12.25.3 Luye Pharma Group Transdermal Therapeutic Systems (TTS) Sales, Revenue and Gross Margin (2016-2021)
12.25.4 Luye Pharma Group Products Offered
12.25.5 Luye Pharma Group Recent Development
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Transdermal Therapeutic Systems (TTS) Industry Trends
13.2 Transdermal Therapeutic Systems (TTS) Market Drivers
13.3 Transdermal Therapeutic Systems (TTS) Market Challenges
13.4 Transdermal Therapeutic Systems (TTS) Market Restraints
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Transdermal Therapeutic Systems (TTS) Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Figures, Tables and Charts Available in Global and United States Transdermal Therapeutic Systems (TTS) Market Insights, Forecast to 2027
List of TablesTable 1. Global Transdermal Therapeutic Systems (TTS) Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
Table 2. Major Manufacturers of Methyl Salicylate
Table 3. Major Manufacturers of Nitroglycerin
Table 4. Major Manufacturers of Fentanyl
Table 5. Major Manufacturers of Nicotine
Table 6. Major Manufacturers of Rivastigmine
Table 7. Major Manufacturers of Estradiol
Table 8. Major Manufacturers of Others
Table 9. Global Transdermal Therapeutic Systems (TTS) Market Size Growth Rate by Application (2021-2027) & (M Units)
Table 10. Global Transdermal Therapeutic Systems (TTS) Market Size by Region (M Units) & (US$ Million), 2016 VS 2021 VS 2027
Table 11. Global Transdermal Therapeutic Systems (TTS) Sales by Regions (2016-2021) & (M Units)
Table 12. Global Transdermal Therapeutic Systems (TTS) Sales Market Share by Regions (2016-2021)
Table 13. Global Transdermal Therapeutic Systems (TTS) Revenue by Regions (2016-2021) & (US$ Million)
Table 14. Global Transdermal Therapeutic Systems (TTS) Sales Forecast by Region (2022-2027) & (M Units)
Table 15. Global Transdermal Therapeutic Systems (TTS) Sales Market Share Forecast by Region (2022-2027)
Table 16. Global Transdermal Therapeutic Systems (TTS) Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 17. Global Transdermal Therapeutic Systems (TTS) Revenue Market Share Forecast by Region (2022-2027)
Table 18. Global Transdermal Therapeutic Systems (TTS) Sales by Manufacturers (2016-2021) (M Units)
Table 19. Global Transdermal Therapeutic Systems (TTS) Sales Share by Manufacturers (2016-2021)
Table 20. Ranking of Global Top Transdermal Therapeutic Systems (TTS) Manufacturers by Revenue (US$ Million) in 2020
Table 21. Transdermal Therapeutic Systems (TTS) Revenue by Manufacturers (2016-2021) (US$ Million)
Table 22. Transdermal Therapeutic Systems (TTS) Revenue Share by Manufacturers (2016-2021)
Table 23. Global Transdermal Therapeutic Systems (TTS) Manufacturers Market Concentration Ratio (CR5 and HHI) & (2016-2021)
Table 24. Global Transdermal Therapeutic Systems (TTS) by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Transdermal Therapeutic Systems (TTS) as of 2020)
Table 25. Key Manufacturers Transdermal Therapeutic Systems (TTS) Price (2016-2021) (USD/K Units)
Table 26. Transdermal Therapeutic Systems (TTS) Manufacturers Manufacturing Base Distribution and Headquarters
Table 27. Manufacturers Transdermal Therapeutic Systems (TTS) Product Type
Table 28. Date of International Manufacturers Enter into Transdermal Therapeutic Systems (TTS) Market
Table 29. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 30. Global Transdermal Therapeutic Systems (TTS) Sales by Type (2016-2021) (M Units)
Table 31. Global Transdermal Therapeutic Systems (TTS) Sales Share by Type (2016-2021)
Table 32. Global Transdermal Therapeutic Systems (TTS) Revenue by Type (2016-2021) (US$ Million)
Table 33. Global Transdermal Therapeutic Systems (TTS) Revenue Share by Type (2016-2021)
Table 34. Transdermal Therapeutic Systems (TTS) Average Selling Price (ASP) by Type (2016-2021) & (USD/K Units)
Table 35. Global Transdermal Therapeutic Systems (TTS) Sales Forecast by Type (2022-2027) & (M Units)
Table 36. Global Transdermal Therapeutic Systems (TTS) Sales Market Share Forecast by Type (2022-2027)
Table 37. Global Transdermal Therapeutic Systems (TTS) Revenue Forecast V (2022-2027) & (US$ Million)
Table 38. Global Transdermal Therapeutic Systems (TTS) Revenue Market Share Forecast by Type (2022-2027)
Table 39. Global Transdermal Therapeutic Systems (TTS) Average Selling Price (ASP) Forecast by Type (2022-2027) & (USD/K Units)
Table 40. Global Transdermal Therapeutic Systems (TTS) Sales by Application (2016-2021) (M Units)
Table 41. Global Transdermal Therapeutic Systems (TTS) Sales Share by Application (2016-2021)
Table 42. Global Transdermal Therapeutic Systems (TTS) Revenue by Application (2016-2021) (US$ Million)
Table 43. Global Transdermal Therapeutic Systems (TTS) Revenue Share by Application (2016-2021)
Table 44. Transdermal Therapeutic Systems (TTS) Average Selling Price (ASP) by Application (2016-2021) & (USD/K Units)
Table 45. Global Transdermal Therapeutic Systems (TTS) Sales Forecast by Application (2022-2027) & (M Units)
Table 46. Global Transdermal Therapeutic Systems (TTS) Sales Market Share Forecast by Application (2022-2027)
Table 47. Global Transdermal Therapeutic Systems (TTS) Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 48. Global Transdermal Therapeutic Systems (TTS) Revenue Market Share Forecast by Application (2022-2027)
Table 49. Global Transdermal Therapeutic Systems (TTS) Average Selling Price (ASP) Forecast by Application (2022-2027) & (USD/K Units)
Table 50. United States Transdermal Therapeutic Systems (TTS) Sales (M Units) of Key Companies (2016-2021)
Table 51. United States Transdermal Therapeutic Systems (TTS) Sales Share by Company (2016-2021)
Table 52. United States Transdermal Therapeutic Systems (TTS) Revenue (US$ Million) by Company (2016-2021)
Table 53. United States Transdermal Therapeutic Systems (TTS) Revenue Share by Company (2016-2021)
Table 54. United States Transdermal Therapeutic Systems (TTS) Sales (M Units) by Type (2016-2021)
Table 55. United States Transdermal Therapeutic Systems (TTS) Sales Share by Type (2016-2021)
Table 56. United States Transdermal Therapeutic Systems (TTS) Revenue (US$ Million) Market Share by Type (2016-2021)
Table 57. United States Transdermal Therapeutic Systems (TTS) Price (USD/K Units) by Type (2016-2021)
Table 58. United States Transdermal Therapeutic Systems (TTS) Sales (M Units) by Type (2022-2027)
Table 59. United States Transdermal Therapeutic Systems (TTS) Sales Share by Type (2022-2027)
Table 60. United States Transdermal Therapeutic Systems (TTS) Revenue (US$ Million) Market Share by Type (2022-2027)
Table 61. United States Transdermal Therapeutic Systems (TTS) Revenue Share by Type (2022-2027)
Table 62. United States Transdermal Therapeutic Systems (TTS) Price (USD/K Units) by Type (2022-2027)
Table 63. United States Transdermal Therapeutic Systems (TTS) Sales (M Units) by Application (2016-2021)
Table 64. United States Transdermal Therapeutic Systems (TTS) Sales Share by Application (2016-2021)
Table 65. United States Transdermal Therapeutic Systems (TTS) Revenue (US$ Million) Market Share by Application (2016-2021)
Table 66. United States Transdermal Therapeutic Systems (TTS) Price (USD/K Units) by Application (2016-2021)
Table 67. United States Transdermal Therapeutic Systems (TTS) Sales (M Units) by Application (2022-2027)
Table 68. United States Transdermal Therapeutic Systems (TTS) Sales Share by Application (2022-2027)
Table 69. United States Transdermal Therapeutic Systems (TTS) Revenue (US$ Million) Market Share by Application (2022-2027)
Table 70. United States Transdermal Therapeutic Systems (TTS) Revenue Share by Application (2022-2027)
Table 71. United States Transdermal Therapeutic Systems (TTS) Price (USD/K Units) by Application (2022-2027)
Table 72. North America Transdermal Therapeutic Systems (TTS) Sales by Country (2016-2021) & (M Units)
Table 73. North America Transdermal Therapeutic Systems (TTS) Sales Market Share by Country (2016-2021)
Table 74. North America Transdermal Therapeutic Systems (TTS) Revenue by Country (2016-2021) & (US$ Million)
Table 75. North America Transdermal Therapeutic Systems (TTS) Revenue Market Share by Country (2016-2021)
Table 76. Asia Pacific Transdermal Therapeutic Systems (TTS) Sales by Region (2016-2021) & (M Units)
Table 77. Asia Pacific Transdermal Therapeutic Systems (TTS) Sales Market Share by Region (2016-2021)
Table 78. Asia Pacific Transdermal Therapeutic Systems (TTS) Revenue by Region (2016-2021) & (US$ Million)
Table 79. Asia Pacific Transdermal Therapeutic Systems (TTS) Revenue Market Share by Region (2016-2021)
Table 80. Europe Transdermal Therapeutic Systems (TTS) Sales by Country (2016-2021) & (M Units)
Table 81. Europe Transdermal Therapeutic Systems (TTS) Sales Market Share by Country (2016-2021)
Table 82. Europe Transdermal Therapeutic Systems (TTS) Revenue by Country (2016-2021) & (US$ Million)
Table 83. Europe Transdermal Therapeutic Systems (TTS) Revenue Market Share by Country (2016-2021)
Table 84. Latin America Transdermal Therapeutic Systems (TTS) Sales by Country (2016-2021) & (M Units)
Table 85. Latin America Transdermal Therapeutic Systems (TTS) Sales Market Share by Country (2016-2021)
Table 86. Latin Americaa Transdermal Therapeutic Systems (TTS) Revenue by Country (2016-2021) & (US$ Million)
Table 87. Latin America Transdermal Therapeutic Systems (TTS) Revenue Market Share by Country (2016-2021)
Table 88. Middle East and Africa Transdermal Therapeutic Systems (TTS) Sales by Country (2016-2021) & (M Units)
Table 89. Middle East and Africa Transdermal Therapeutic Systems (TTS) Sales Market Share by Country (2016-2021)
Table 90. Middle East and Africa Transdermal Therapeutic Systems (TTS) Revenue by Country (2016-2021) & (US$ Million)
Table 91. Middle East and Africa Transdermal Therapeutic Systems (TTS) Revenue Market Share by Country (2016-2021)
Table 92. Hisamitsu Corporation Information
Table 93. Hisamitsu Description and Business Overview
Table 94. Hisamitsu Transdermal Therapeutic Systems (TTS) Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2016-2021)
Table 95. Hisamitsu Transdermal Therapeutic Systems (TTS) Product
Table 96. Hisamitsu Recent Development
Table 97. Mylan Corporation Information
Table 98. Mylan Description and Business Overview
Table 99. Mylan Transdermal Therapeutic Systems (TTS) Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2016-2021)
Table 100. Mylan Product
Table 101. Mylan Recent Development
Table 102. GSK Corporation Information
Table 103. GSK Description and Business Overview
Table 104. GSK Transdermal Therapeutic Systems (TTS) Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2016-2021)
Table 105. GSK Product
Table 106. GSK Recent Development
Table 107. Novartis Corporation Information
Table 108. Novartis Description and Business Overview
Table 109. Novartis Transdermal Therapeutic Systems (TTS) Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2016-2021)
Table 110. Novartis Product
Table 111. Novartis Recent Development
Table 112. Teve (Actavis) Corporation Information
Table 113. Teve (Actavis) Description and Business Overview
Table 114. Teve (Actavis) Transdermal Therapeutic Systems (TTS) Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2016-2021)
Table 115. Teve (Actavis) Product
Table 116. Teve (Actavis) Recent Development
Table 117. Nitto Denko Corporation Information
Table 118. Nitto Denko Description and Business Overview
Table 119. Nitto Denko Transdermal Therapeutic Systems (TTS) Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2016-2021)
Table 120. Nitto Denko Product
Table 121. Nitto Denko Recent Development
Table 122. Johnson & Johnson Corporation Information
Table 123. Johnson & Johnson Description and Business Overview
Table 124. Johnson & Johnson Transdermal Therapeutic Systems (TTS) Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2016-2021)
Table 125. Johnson & Johnson Product
Table 126. Johnson & Johnson Recent Development
Table 127. Lohmann Corporation Information
Table 128. Lohmann Description and Business Overview
Table 129. Lohmann Transdermal Therapeutic Systems (TTS) Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2016-2021)
Table 130. Lohmann Product
Table 131. Lohmann Recent Development
Table 132. Teikoku Seiyaku Corporation Information
Table 133. Teikoku Seiyaku Description and Business Overview
Table 134. Teikoku Seiyaku Transdermal Therapeutic Systems (TTS) Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2016-2021)
Table 135. Teikoku Seiyaku Product
Table 136. Teikoku Seiyaku Recent Development
Table 137. Pfizer Corporation Information
Table 138. Pfizer Description and Business Overview
Table 139. Pfizer Transdermal Therapeutic Systems (TTS) Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2016-2021)
Table 140. Pfizer Product
Table 141. Pfizer Recent Development
Table 142. Bayer Corporation Information
Table 143. Bayer Description and Business Overview
Table 144. Bayer Transdermal Therapeutic Systems (TTS) Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2016-2021)
Table 145. Bayer Product
Table 146. Bayer Recent Development
Table 147. Lingrui Corporation Information
Table 148. Lingrui Description and Business Overview
Table 149. Lingrui Transdermal Therapeutic Systems (TTS) Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2016-2021)
Table 150. Lingrui Product
Table 151. Lingrui Recent Development
Table 152. Sanofi Corporation Information
Table 153. Sanofi Description and Business Overview
Table 154. Sanofi Transdermal Therapeutic Systems (TTS) Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2016-2021)
Table 155. Sanofi Product
Table 156. Sanofi Recent Development
Table 157. UCB Pharma Corporation Information
Table 158. UCB Pharma Description and Business Overview
Table 159. UCB Pharma Transdermal Therapeutic Systems (TTS) Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2016-2021)
Table 160. UCB Pharma Product
Table 161. UCB Pharma Recent Development
Table 162. Dr. Reddy's Laboratories Corporation Information
Table 163. Dr. Reddy's Laboratories Description and Business Overview
Table 164. Dr. Reddy's Laboratories Transdermal Therapeutic Systems (TTS) Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2016-2021)
Table 165. Dr. Reddy's Laboratories Product
Table 166. Dr. Reddy's Laboratories Recent Development
Table 167. Qizheng Corporation Information
Table 168. Qizheng Description and Business Overview
Table 169. Qizheng Transdermal Therapeutic Systems (TTS) Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2016-2021)
Table 170. Qizheng Product
Table 171. Qizheng Recent Development
Table 172. Endo Corporation Information
Table 173. Endo Description and Business Overview
Table 174. Endo Transdermal Therapeutic Systems (TTS) Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2016-2021)
Table 175. Endo Product
Table 176. Endo Recent Development
Table 177. Mundipharma Corporation Information
Table 178. Mundipharma Description and Business Overview
Table 179. Mundipharma Transdermal Therapeutic Systems (TTS) Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2016-2021)
Table 180. Mundipharma Product
Table 181. Mundipharma Recent Development
Table 182. Huarun 999 Corporation Information
Table 183. Huarun 999 Description and Business Overview
Table 184. Huarun 999 Transdermal Therapeutic Systems (TTS) Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2016-2021)
Table 185. Huarun 999 Product
Table 186. Huarun 999 Recent Development
Table 187. Haw Par Corporation Information
Table 188. Haw Par Description and Business Overview
Table 189. Haw Par Transdermal Therapeutic Systems (TTS) Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2016-2021)
Table 190. Haw Par Product
Table 191. Haw Par Recent Development
Table 192. Nichiban Corporation Information
Table 193. Nichiban Description and Business Overview
Table 194. Nichiban Transdermal Therapeutic Systems (TTS) Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2016-2021)
Table 195. Nichiban Product
Table 196. Nichiban Recent Development
Table 197. Mentholatum Company Corporation Information
Table 198. Mentholatum Company Description and Business Overview
Table 199. Mentholatum Company Transdermal Therapeutic Systems (TTS) Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2016-2021)
Table 200. Mentholatum Company Product
Table 201. Mentholatum Company Recent Development
Table 202. Laboratoires Genevrier Corporation Information
Table 203. Laboratoires Genevrier Description and Business Overview
Table 204. Laboratoires Genevrier Transdermal Therapeutic Systems (TTS) Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2016-2021)
Table 205. Laboratoires Genevrier Product
Table 206. Laboratoires Genevrier Recent Development
Table 207. Beijing Tide Pharmaceutical Corporation Information
Table 208. Beijing Tide Pharmaceutical Description and Business Overview
Table 209. Beijing Tide Pharmaceutical Transdermal Therapeutic Systems (TTS) Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2016-2021)
Table 210. Beijing Tide Pharmaceutical Product
Table 211. Beijing Tide Pharmaceutical Recent Development
Table 212. Luye Pharma Group Corporation Information
Table 213. Luye Pharma Group Description and Business Overview
Table 214. Luye Pharma Group Transdermal Therapeutic Systems (TTS) Sales (M Units), Revenue (US$ Million), Price (USD/K Units) and Gross Margin (2016-2021)
Table 215. Luye Pharma Group Product
Table 216. Luye Pharma Group Recent Development
Table 217. Transdermal Therapeutic Systems (TTS) Market Trends
Table 218. Transdermal Therapeutic Systems (TTS) Market Drivers
Table 219. Transdermal Therapeutic Systems (TTS) Market Challenges
Table 220. Transdermal Therapeutic Systems (TTS) Market Restraints
Table 221. Transdermal Therapeutic Systems (TTS) Customers List
Table 222. Transdermal Therapeutic Systems (TTS) Distributors List
Table 223. Research Programs/Design for This Report
Table 224. Key Data Information from Secondary Sources
Table 225. Key Data Information from Primary Sources
List of Figures
Figure 1. Transdermal Therapeutic Systems (TTS) Product Picture
Figure 2. Global Transdermal Therapeutic Systems (TTS) Sales Market Share by Type in 2020 & 2027
Figure 3. Methyl Salicylate Product Picture
Figure 4. Nitroglycerin Product Picture
Figure 5. Fentanyl Product Picture
Figure 6. Nicotine Product Picture
Figure 7. Rivastigmine Product Picture
Figure 8. Estradiol Product Picture
Figure 9. Others Product Picture
Figure 10. Global Transdermal Therapeutic Systems (TTS) Sales Market Share by Application in 2020 & 2027
Figure 11. OTC Channel
Figure 12. Retail Channel
Figure 13. E-Commerce Channel
Figure 14. Transdermal Therapeutic Systems (TTS) Report Years Considered
Figure 15. Global Transdermal Therapeutic Systems (TTS) Market Size, (US$ Million), 2016 VS 2021 VS 2027
Figure 16. Global Transdermal Therapeutic Systems (TTS) Market Size 2016-2027 (US$ Million)
Figure 17. Global Transdermal Therapeutic Systems (TTS) Sales 2016-2027 (M Units)
Figure 18. Global Transdermal Therapeutic Systems (TTS) Market Size Market Share by Region: 2021 Versus 2027
Figure 19. Global Transdermal Therapeutic Systems (TTS) Sales Market Share by Region (2016-2021)
Figure 20. Global Transdermal Therapeutic Systems (TTS) Sales Market Share by Region in 2020
Figure 21. Global Transdermal Therapeutic Systems (TTS) Revenue Market Share by Region (2016-2021)
Figure 22. Global Transdermal Therapeutic Systems (TTS) Revenue Market Share by Region in 2020
Figure 23. Global Transdermal Therapeutic Systems (TTS) Sales Share by Manufacturer in 2020
Figure 24. The Top 10 and 5 Players Market Share by Transdermal Therapeutic Systems (TTS) Revenue in 2020
Figure 25. Transdermal Therapeutic Systems (TTS) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 26. Global Transdermal Therapeutic Systems (TTS) Sales Market Share by Type (2016-2021)
Figure 27. Global Transdermal Therapeutic Systems (TTS) Sales Market Share by Type in 2020
Figure 28. Global Transdermal Therapeutic Systems (TTS) Revenue Market Share by Type (2016-2021)
Figure 29. Global Transdermal Therapeutic Systems (TTS) Revenue Market Share by Type in 2020
Figure 30. Global Transdermal Therapeutic Systems (TTS) Sales Market Share by Application (2016-2021)
Figure 31. Global Transdermal Therapeutic Systems (TTS) Sales Market Share by Application in 2020
Figure 32. Global Transdermal Therapeutic Systems (TTS) Revenue Market Share by Application (2016-2021)
Figure 33. Global Transdermal Therapeutic Systems (TTS) Revenue Market Share by Application in 2020
Figure 34. United States Transdermal Therapeutic Systems (TTS) Sales Growth Rate 2016-2027 (M Units)
Figure 35. United States Transdermal Therapeutic Systems (TTS) Revenue Growth Rate 2016-2027 (US$ Million)
Figure 36. United States Transdermal Therapeutic Systems (TTS) Market Share in Global Market 2016-2027
Figure 37. United States 5 and 10 Largest Transdermal Therapeutic Systems (TTS) Players Market Share by Revenue in Transdermal Therapeutic Systems (TTS) in 2020
Figure 38. United States Transdermal Therapeutic Systems (TTS) Revenue Share by Type (2016-2021)
Figure 39. United States Transdermal Therapeutic Systems (TTS) Revenue Growth Rate by Type in 2016 & 2020
Figure 40. United States Transdermal Therapeutic Systems (TTS) Revenue Share by Application (2016-2021)
Figure 41. United States Transdermal Therapeutic Systems (TTS) Revenue Growth Rate by Application in 2016 & 2020
Figure 42. North America Transdermal Therapeutic Systems (TTS) Sales Growth Rate 2016-2021 (M Units)
Figure 43. North America Transdermal Therapeutic Systems (TTS) Revenue Growth Rate 2016-2021 (US$ Million)
Figure 44. North America Transdermal Therapeutic Systems (TTS) Sales Market Share by Country in 2020
Figure 45. North America Transdermal Therapeutic Systems (TTS) Revenue Market Share by Country in 2020
Figure 46. United States Transdermal Therapeutic Systems (TTS) Sales Growth Rate (2016-2021) (M Units)
Figure 47. United States Transdermal Therapeutic Systems (TTS) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 48. Canada Transdermal Therapeutic Systems (TTS) Sales Growth Rate (2016-2021) (M Units)
Figure 49. Canada Transdermal Therapeutic Systems (TTS) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 50. Europe Transdermal Therapeutic Systems (TTS) Sales Growth Rate 2016-2021 (M Units)
Figure 51. Europe Transdermal Therapeutic Systems (TTS) Revenue Growth Rate 2016-2021 (US$ Million)
Figure 52. Europe Transdermal Therapeutic Systems (TTS) Sales Market Share by Country in 2020
Figure 53. Europe Transdermal Therapeutic Systems (TTS) Revenue Market Share by Country in 2020
Figure 54. Germany Transdermal Therapeutic Systems (TTS) Sales Growth Rate (2016-2021) (M Units)
Figure 55. Germany Transdermal Therapeutic Systems (TTS) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 56. France Transdermal Therapeutic Systems (TTS) Sales Growth Rate (2016-2021) (M Units)
Figure 57. France Transdermal Therapeutic Systems (TTS) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 58. U.K. Transdermal Therapeutic Systems (TTS) Sales Growth Rate (2016-2021) (M Units)
Figure 59. U.K. Transdermal Therapeutic Systems (TTS) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 60. Italy Transdermal Therapeutic Systems (TTS) Sales Growth Rate (2016-2021) (M Units)
Figure 61. Italy Transdermal Therapeutic Systems (TTS) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 62. Russia Transdermal Therapeutic Systems (TTS) Sales Growth Rate (2016-2021) (M Units)
Figure 63. Russia Transdermal Therapeutic Systems (TTS) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 64. Asia Pacific Transdermal Therapeutic Systems (TTS) Sales Growth Rate 2016-2021 (M Units)
Figure 65. Asia Pacific Transdermal Therapeutic Systems (TTS) Revenue Growth Rate 2016-2021 (US$ Million)
Figure 66. Asia Pacific Transdermal Therapeutic Systems (TTS) Sales Market Share by Region in 2020
Figure 67. Asia Pacific Transdermal Therapeutic Systems (TTS) Revenue Market Share by Region in 2020
Figure 68. China Transdermal Therapeutic Systems (TTS) Sales Growth Rate (2016-2021) (M Units)
Figure 69. China Transdermal Therapeutic Systems (TTS) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 70. Japan Transdermal Therapeutic Systems (TTS) Sales Growth Rate (2016-2021) (M Units)
Figure 71. Japan Transdermal Therapeutic Systems (TTS) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 72. South Korea Transdermal Therapeutic Systems (TTS) Sales Growth Rate (2016-2021) (M Units)
Figure 73. South Korea Transdermal Therapeutic Systems (TTS) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 74. India Transdermal Therapeutic Systems (TTS) Sales Growth Rate (2016-2021) (M Units)
Figure 75. India Transdermal Therapeutic Systems (TTS) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 76. Australia Transdermal Therapeutic Systems (TTS) Sales Growth Rate (2016-2021) (M Units)
Figure 77. Australia Transdermal Therapeutic Systems (TTS) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 78. China Taiwan Transdermal Therapeutic Systems (TTS) Sales Growth Rate (2016-2021) (M Units)
Figure 79. China Taiwan Transdermal Therapeutic Systems (TTS) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 80. Indonesia Transdermal Therapeutic Systems (TTS) Sales Growth Rate (2016-2021) (M Units)
Figure 81. Indonesia Transdermal Therapeutic Systems (TTS) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 82. Thailand Transdermal Therapeutic Systems (TTS) Sales Growth Rate (2016-2021) (M Units)
Figure 83. Thailand Transdermal Therapeutic Systems (TTS) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 84. Malaysia Transdermal Therapeutic Systems (TTS) Sales Growth Rate (2016-2021) (M Units)
Figure 85. Malaysia Transdermal Therapeutic Systems (TTS) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 86. Latin America Transdermal Therapeutic Systems (TTS) Sales Growth Rate 2016-2021 (M Units)
Figure 87. Latin America Transdermal Therapeutic Systems (TTS) Revenue Growth Rate 2016-2021 (US$ Million)
Figure 88. Latin America Transdermal Therapeutic Systems (TTS) Sales Market Share by Country in 2020
Figure 89. Latin America Transdermal Therapeutic Systems (TTS) Revenue Market Share by Country in 2020
Figure 90. Mexico Transdermal Therapeutic Systems (TTS) Sales Growth Rate (2016-2021) (M Units)
Figure 91. Mexico Transdermal Therapeutic Systems (TTS) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 92. Brazil Transdermal Therapeutic Systems (TTS) Sales Growth Rate (2016-2021) (M Units)
Figure 93. Brazil Transdermal Therapeutic Systems (TTS) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 94. Argentina Transdermal Therapeutic Systems (TTS) Sales Growth Rate (2016-2021) (M Units)
Figure 95. Argentina Transdermal Therapeutic Systems (TTS) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 96. Middle East and Africa Transdermal Therapeutic Systems (TTS) Sales Growth Rate 2016-2021 (M Units)
Figure 97. Middle East and Africa Transdermal Therapeutic Systems (TTS) Revenue Growth Rate 2016-2021 (US$ Million)
Figure 98. Middle East and Africa Transdermal Therapeutic Systems (TTS) Sales Market Share by Country in 2020
Figure 99. Middle East and Africa Transdermal Therapeutic Systems (TTS) Revenue Market Share by Country in 2020
Figure 100. Turkey Transdermal Therapeutic Systems (TTS) Sales Growth Rate (2016-2021) (M Units)
Figure 101. Turkey Transdermal Therapeutic Systems (TTS) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 102. Saudi Arabia Transdermal Therapeutic Systems (TTS) Sales Growth Rate (2016-2021) (M Units)
Figure 103. Saudi Arabia Transdermal Therapeutic Systems (TTS) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 104. UAE Transdermal Therapeutic Systems (TTS) Sales Growth Rate (2016-2021) (M Units)
Figure 105. UAE Transdermal Therapeutic Systems (TTS) Revenue Growth Rate (2016-2021) (US$ Million)
Figure 106. Transdermal Therapeutic Systems (TTS) Value Chain
Figure 107. Channels of Distribution
Figure 108. Distributors Profiles
Figure 109. Bottom-up and Top-down Approaches for This Report
Figure 110. Data Triangulation
Figure 111. Key Executives Interviewed
Keyplayers in Global and United States Transdermal Therapeutic Systems (TTS) Market Insights, Forecast to 2027
HisamitsuMylan
GSK
Novartis
Teve (Actavis)
Nitto Denko
Johnson & Johnson
Lohmann
Teikoku Seiyaku
Pfizer
Bayer
Lingrui
Sanofi
UCB Pharma
Dr. Reddy's Laboratories
Qizheng
Endo
Mundipharma
Huarun 999
Haw Par
Nichiban
Mentholatum Company
Laboratoires Genevrier
Beijing Tide Pharmaceutical
Luye Pharma Group
Request Sample
Request Discount
